Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children.
about
Complement and contact activation in term neonates after fetal acidosis.Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.Ulinastatin as a neuroprotective and anti-inflammatory agent in infant piglets model undergoing surgery on hypothermic low-flow cardiopulmonary bypass.In vitro evaluation of PHISIO-coated sets for pediatric cardiac surgery.Depressed thyroid function following paediatric cardiopulmonary bypass: association with interleukin-6 release?
P2860
Complement activation and release of tumour necrosis factor alpha, interleukin-2, interleukin-6 and soluble tumour necrosis factor and interleukin-2 receptors during and after cardiopulmonary bypass in children.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Complement activation and rele ...... opulmonary bypass in children.
@en
Complement activation and rele ...... opulmonary bypass in children.
@nl
type
label
Complement activation and rele ...... opulmonary bypass in children.
@en
Complement activation and rele ...... opulmonary bypass in children.
@nl
prefLabel
Complement activation and rele ...... opulmonary bypass in children.
@en
Complement activation and rele ...... opulmonary bypass in children.
@nl
P2093
P2860
P1476
Complement activation and rele ...... opulmonary bypass in children.
@en
P2093
P2860
P356
10.3109/00365519509075381
P577
1995-02-01T00:00:00Z